Literature DB >> 11358461

Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects.

R H Swerdlow1, J K Parks, D S Cassarino, D R Binder, J P Bennett, G Di Iorio, L I Golbe, W D Parker.   

Abstract

Complex I activity is reduced in cytoplasmic hybrid (cybrid) cell lines that contain mitochondrial DNA (mtDNA) from sporadic Parkinson's disease (PD) patients. This implies that mtDNA aberration occurs in sporadic PD. To assess the integrity of mtDNA in autosomal dominant PD arising from mutation of the alpha-synuclein gene, we transferred mitochondrial genes from PD-affected members of the Italian-American Contursi kindred to cells previously depleted of their endogenous mtDNA. Unlike cybrid cell lines expressing mtDNA from persons with sporadic or maternally inherited PD, the resultant Contursi cybrid lines did not manifest complex I deficiency, indicating that in Contursi PD mtDNA integrity is relatively preserved. Compared to control cybrids, however, Contursi cybrid lines did show some evidence of oxidative stress. For reasons that are unclear, at least a limited amount of mtDNA damage may nevertheless develop in PD patients with alpha-synuclein mutation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358461     DOI: 10.1006/exnr.2001.7674

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

Review 1.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration.

Authors:  Romana Fato; Christian Bergamini; Serena Leoni; Paola Strocchi; Giorgio Lenaz
Journal:  Neurochem Res       Date:  2008-06-06       Impact factor: 3.996

Review 3.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 4.  Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

5.  Mitochondrial contribution to Parkinson's disease pathogenesis.

Authors:  Anthony H V Schapira; Matthew Gegg
Journal:  Parkinsons Dis       Date:  2011-04-28

6.  Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships.

Authors:  Paula M Keeney; Lisa D Dunham; Caitlin K Quigley; Stephanie L Morton; Kristen E Bergquist; James P Bennett
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

Review 7.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

Authors:  Sudhakar Raja Subramaniam; Marie-Francoise Chesselet
Journal:  Prog Neurobiol       Date:  2013-04-30       Impact factor: 11.685

8.  Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

Authors:  Samantha Giordano; Jisun Lee; Victor M Darley-Usmar; Jianhua Zhang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

9.  Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?

Authors:  Joanne Clark; Ying Dai; David K Simon
Journal:  Parkinsons Dis       Date:  2011-04-27

Review 10.  The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.

Authors:  Pamela J Urrutia; Natalia P Mena; Marco T Núñez
Journal:  Front Pharmacol       Date:  2014-03-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.